Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry

Affiliations

¹ Department of Hematology and Medical Oncology, Mount Sinai Hospital, New York, NY. Electronic address: sundar.jagannath@mountsinai.org.
² Department of Medical Oncology/Hematology, Rocky Mountain Cancer Centers US Oncology, Denver, CO.
³ Department of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC.
⁴ Department of Internal Medicine, Medical Oncology, and Hematology, Steeplechase Cancer Center, Somerville, NJ.
⁵ Department of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA.
⁶ Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC.
⁷ Department of Hematology, Internal Medicine, and Medical Oncology, Providence Cancer Institute, Southfield, MI.
⁸ Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC.
⁹ Department of Medical Oncology/Hematology, US Oncology Research, Columbia, MD.
¹⁰ Department of Hematology, Mayo Clinic, Jacksonville, FL.
¹¹ Myeloma Research Advocate/Advisor, Grand Island, NE.
¹² Celgene Corporation, Summit, NJ.
¹³ Department of Hematology/Oncology, Indiana University, Indianapolis, IN.

Free article

Sundar Jagannath et al. Clin Lymphoma Myeloma Leuk. 2020 May.

Free article

. 2020 May;20(5):272-276.

doi: 10.1016/j.clml.2019.10.002. Epub 2019 Oct 14.

¹ Department of Hematology and Medical Oncology, Mount Sinai Hospital, New York, NY. Electronic address: sundar.jagannath@mountsinai.org.
² Department of Medical Oncology/Hematology, Rocky Mountain Cancer Centers US Oncology, Denver, CO.
³ Department of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC.
⁴ Department of Internal Medicine, Medical Oncology, and Hematology, Steeplechase Cancer Center, Somerville, NJ.
⁵ Department of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA.
⁶ Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC.
⁷ Department of Hematology, Internal Medicine, and Medical Oncology, Providence Cancer Institute, Southfield, MI.
⁸ Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC.
⁹ Department of Medical Oncology/Hematology, US Oncology Research, Columbia, MD.
¹⁰ Department of Hematology, Mayo Clinic, Jacksonville, FL.
¹¹ Myeloma Research Advocate/Advisor, Grand Island, NE.
¹² Celgene Corporation, Summit, NJ.
¹³ Department of Hematology/Oncology, Indiana University, Indianapolis, IN.

No abstract available

Keywords: Community; Real-world; Sankey; Therapies; Transitions.

Publication types